Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Delgado

Showing results (101-110 of 173) with videos related to

Pageof 18
Sort By:
Arthritis and Rheumatism|April 3, 2008
In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritisMario Delgado, Miguel G Toscano, Karim Benabdellah, et al.
Annals of the New York Academy of Sciences|August 5, 2006
VIP prevents experimental multiple sclerosis by downregulating both inflammatory and autoimmune components of the diseaseAmelia Fernandez-Martin, Elena Gonzalez-Rey, Alejo Chorny, et al.
Journal of Tissue Engineering and Regenerative Medicine|July 12, 2016
Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage featuresMarta Magatti, Elsa Vertua, Silvia De Munari, et al.
Stem Cells (Dayton, Ohio)|March 21, 2014
miR-335 correlates with senescence/aging in human mesenchymal stem cells and inhibits their therapeutic actions through inhibition of AP-1 activityMaría Tomé, Juan Carlos Sepúlveda, Mario Delgado, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disordersOrnella Parolini, Luciana Souza-Moreira, Francisco O'Valle, et al.
Stem Cells (Dayton, Ohio)|February 6, 2014
Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia modelJuan Carlos Sepúlveda, María Tomé, María Eugenia Fernández, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 22, 2024
Dietary Vitamin C Intake and Changes in Frequency, Severity, and Location of Pain in Older AdultsMario Delgado-Velandia, Rosario Ortolá, Esther García-Esquinas, et al.
Quality & Safety in Health Care|December 4, 2010
Quality assessment of clinical practice guidelines in perioperative care: a systematic appraisalLeticia Barajas-Nava, Ivan Solà, Mario Delgado-Noguera, et al.
Plos One|November 1, 2007
Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 responseElena Gonzalez-Rey, Ruben Martínez-Romero, Francisco O'Valle, et al.
Surgical Infections|April 22, 2025
Splenectomy for the Treatment of Splenomegaly in People Living with HIV: An Uncommon ComplicationPablo Gomes-da Silva de Rosenzweig, Oscar Mario Delgado-Casillas, Juan Carlos Vázquez-Minero, et al.
Pageof 18

Showing results (101-110 of 173) with videos related to

Sort By:
Pageof 18
Arthritis and Rheumatism|April 3, 2008
In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritisMario Delgado, Miguel G Toscano, Karim Benabdellah, et al.
Annals of the New York Academy of Sciences|August 5, 2006
VIP prevents experimental multiple sclerosis by downregulating both inflammatory and autoimmune components of the diseaseAmelia Fernandez-Martin, Elena Gonzalez-Rey, Alejo Chorny, et al.
Journal of Tissue Engineering and Regenerative Medicine|July 12, 2016
Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage featuresMarta Magatti, Elsa Vertua, Silvia De Munari, et al.
Stem Cells (Dayton, Ohio)|March 21, 2014
miR-335 correlates with senescence/aging in human mesenchymal stem cells and inhibits their therapeutic actions through inhibition of AP-1 activityMaría Tomé, Juan Carlos Sepúlveda, Mario Delgado, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disordersOrnella Parolini, Luciana Souza-Moreira, Francisco O'Valle, et al.
Stem Cells (Dayton, Ohio)|February 6, 2014
Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia modelJuan Carlos Sepúlveda, María Tomé, María Eugenia Fernández, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 22, 2024
Dietary Vitamin C Intake and Changes in Frequency, Severity, and Location of Pain in Older AdultsMario Delgado-Velandia, Rosario Ortolá, Esther García-Esquinas, et al.
Quality & Safety in Health Care|December 4, 2010
Quality assessment of clinical practice guidelines in perioperative care: a systematic appraisalLeticia Barajas-Nava, Ivan Solà, Mario Delgado-Noguera, et al.
Plos One|November 1, 2007
Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 responseElena Gonzalez-Rey, Ruben Martínez-Romero, Francisco O'Valle, et al.
Surgical Infections|April 22, 2025
Splenectomy for the Treatment of Splenomegaly in People Living with HIV: An Uncommon ComplicationPablo Gomes-da Silva de Rosenzweig, Oscar Mario Delgado-Casillas, Juan Carlos Vázquez-Minero, et al.
Pageof 18